On 2024-11-07, ADC Therapeutics SA (ADCT) announced earnings per share of $-0.42 for the fiscal quarter ending 2024-09-30, missing the average analyst estimate of $-0.36.
The next expected annoucement date for quarterly earnings is 2025-03-12, with an average estimated earnings per share of $-0.39 for the fiscal quarter ending 2024-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-11-07 | 2024-09-30 | $-0.36 | $-0.42 |
| 2024-08-06 | 2024-06-30 | $-0.44 | $-0.38 |
| 2024-05-06 | 2024-03-31 | $-0.56 | $-0.56 |
| 2024-03-13 | 2023-12-31 | $-0.47 | $-1.03 |
| 2023-11-07 | 2023-09-30 | $-0.61 | $-0.58 |
| 2023-08-08 | 2023-06-30 | $-0.44 | $-0.58 |
| 2023-05-09 | 2023-03-31 | $-0.80 | $-0.74 |
| 2023-02-28 | 2022-12-31 | $-0.49 | $-0.30 |
| 2022-11-08 | 2022-09-30 | $-0.51 | $-0.65 |
| 2022-08-09 | 2022-06-30 | $-0.96 | $-0.84 |
| 2022-05-09 | 2022-03-31 | $-0.76 | $-0.22 |
| 2022-03-03 | 2021-12-31 | $-0.87 | $-0.45 |
| 2021-11-02 | 2021-09-30 | $-1.16 | $-0.93 |
| 2021-08-03 | 2021-06-30 | $-0.84 | $-0.95 |
| 2021-05-06 | 2021-03-31 | $-1.00 | $-0.67 |
| 2021-03-18 | 2020-12-31 | $-0.68 | $-0.73 |
| 2020-11-12 | 2020-09-30 | $-0.77 | $-0.29 |
| 2020-08-18 | 2020-06-30 | $-0.96 | $-0.71 |